FCGR2A and COVID-19: Despite the low levels of mucosal neutralizing antibodies, we have shown above that antibodies mediating FcγR engagement were detectable in saliva and tear fluid, particularly in COVID-19–recovered vaccinees after their second mRNA vaccine (1 × prior infection + 2 × BNT162b2) (Figure 1C).